Generic Drugs Have a Friend in 'the Formulary'

Coopman, Robert
February 2011
Chain Drug Review;2/28/2011, Vol. 33 Issue 4, p66
Trade Publication
The article focuses on the formulary in the generic drug industry, in which the loss of brand patent protection does not render a generic version less effective while the brand patent protection render the brand a superior therapeutic choice in the U.S.


Related Articles

  • A run on brand x. Montague, Jim // H&HN: Hospitals & Health Networks;9/05/96, Vol. 70 Issue 17, p16 

    Cites a survey of international medicine doctors conducted by Hospital Research Associates which found that managed care plans' formularies cause the doctors to prescribe generic drugs more often. Forecast on generic drug prescription.

  • Pharmacists unwilling to substitute generics for some critical-dose drugs, despite payer policy...  // Hospital Formulary;Feb95, Vol. 30 Issue 2, p71 

    Reports survey findings that most pharmacists feel comfortable substituting generic drugs for brand-name drugs except for narrow-index drugs like Coumadin, Dilantin and Lanoxin. Reluctance to substitute a generic product in cases where a third-party payer required substitution; Consideration of...

  • Not exactly what the doctor ordered. Troy, Terry // Dermatology Times;Jan1999, Vol. 20 Issue 1, p14 

    Focuses on a survey of several pharmacies in Cleveland, Ohio conducted by `Dermatology Times' periodical after receiving complaints that pharmacists substitute generic and over-the-counter products for prescribed medicine. Response of a regional discount drug chain and three national drug...

  • Levetiracetam.  // Reactions Weekly;1/9/2010 Part 2 of 2, Issue 1283, p60 

    The article describes three cases of recurrent seizures after switching from branded to generic levetiracetam, an anticonvulsant.

  • 20 years ago.  // European Chemical News;2/3/2003, Vol. 78 Issue 2038, p21 

    Provides an overview of issues on the generic substitution of drugs in Great Britain in an effort to save money for the health service in January 1983. Estimation of savings from the generic substitution of drugs; Products recommended for generic substitution; Issue pointed out by drug makers.

  • FDA ATTACKS ANTIGENERIC LOBBYING EFFORT.  // H&HN: Hospitals & Health Networks;02/20/98, Vol. 72 Issue 4, p100 

    States that the United States Food and Drug Administration (FDA) defended the use of generic drugs, and criticized drugmakers for their efforts to prevent pharmacies from automatically substituting generic versions of brand names. Reference made to the drug, Coumadin; Why pharmacies are...

  • Generic prescribing: time to regulate the market? Walley, T.; Burrill, Peter // BMJ: British Medical Journal (International Edition);01/15/2000, Vol. 320 Issue 7228, p131 

    Discusses the importance of market regulations for generic medicines in Great Britain. Advantages of prescribing medicines by generic; Factors that contributed to the price increases for generic medicines in 1999.

  • Savings from use of generics could be much higher.  // PharmacoEconomics & Outcomes News;9/7/2013, Issue 686, p8 

    The article reports that savings from the entry of generic versions of prescription drugs are not completely realised by private payers because many branded drugs are still bought when new generic drugs become available, according to Canadian researchers.

  • GENERIC DRUG FACTS.  // Monthly Prescribing Reference;Sep2011, Vol. 27 Issue 9, pA12 

    The article offers information on pharmaceutical equivalent and pharmaceutical alternative drug products.

  • Generic drugs, less money same quality.  // Southern Illinois Labor Tribune;6/2/2011, Vol. 74 Issue 44, p11 

    The article offers information on the differences of generic drugs compared to brand name products along with their safety, lesser costs, and availability in the U.S.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics